National Institute of Biomedical Imaging and Bioengineering; Notice of Closed Meeting, 23192-23193 [E9-11487]
Download as PDF
23192
Federal Register / Vol. 74, No. 94 / Monday, May 18, 2009 / Notices
soon as possible after the meeting, either
by accessing the SAMHSA Committee
Web site, https://www.nac.samhsa.gov/
DTAB/meetings.aspx, or by contacting
Ms. Hersh. The transcript for the
meeting will also be available on the
SAMHSA Committee Web site within
three weeks after the meeting.
Committee Name: Substance Abuse and
Mental Health Services Administration Drug
Testing Advisory Board.
Date/Time/Type: June 2, 2009 from 10 a.m.
to 4:30 p.m. EDT: OPEN. June 3, 2009 from
10 a.m. to 1 p.m. EDT: OPEN.
Place: Sugarloaf and Seneca Conference
Rooms, 1 Choke Cherry Road, Rockville,
Maryland 20857.
Contact: Ms. Giselle Hersh, Program
Assistant, SAMHSA Drug Testing Advisory
Board, 1 Choke Cherry Road, Room 2–1042,
Rockville, Maryland 20857, Telephone: 240–
276–2600, Fax: 240–276–2610, E-mail:
Giselle.Hersh@samhsa.hhs.gov.
Toian Vaughn,
Committee Management Officer, Substance
Abuse and Mental Health, Services
Administration.
[FR Doc. E9–11427 Filed 5–15–09; 8:45 am]
BILLING CODE 4162–20–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Neurological
Disorders and Stroke; Notice of Closed
Meetings
cprice-sewell on PRODPC61 with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Neurological Disorders and Stroke Initial
Review Group; Neurological Sciences and
Disorders C.
Date: June 8–9, 2009
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: The Fairmont Washington, DC, 2401
M Street, NW., Washington, DC 20037.
Contact Person: William C. Benzing, PhD,
Scientific Review Administrator, Scientific
Review Branch, Division Of Extramural
Research, NINDS/NIH/DHHS/Neuroscience
VerDate Nov<24>2008
14:36 May 15, 2009
Jkt 217001
Center, 6001 Executive Boulevard, Suite
3208, MSC 9529, Bethesda, MD 20892, (301)
496–0660, benzingw@mail.nih.gov.
Name of Committee: National Institute of
Neurological Disorders and Stroke Initial
Review Group; Neurological Sciences and
Disorders A.
Date: June 24, 2009
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Ritz Carlton Hotel, 1150 22nd Street,
NW., Washington, DC 20037.
Contact Person: Richard D. Crosland, PhD,
Scientific Review Officer, Scientific Review
Branch, Division of Extramural Research,
NINDS/NIH/DHHS, Neuroscience Center,
6001 Executive Blvd., Suite 3208, MSC 9529,
Bethesda, MD 20892–9529, 301–496–9223.
Name of Committee: National Institute of
Neurological Disorders and Stroke Initial
Review Group; Neurological Sciences and
Disorders B.
Date: June 25–26, 2009.
Time: 7 a.m. to 7 p.m.
Agenda: To review and evaluate grant
applications.
Place: State Plaza Hotel, 2117 E Street,
NW., Washington, DC 20037.
Contact Person: Ernest W Lyons, PhD,
Scientific Review Officer, Scientific Review
Branch, NINDS/NIH/DHHS, Neuroscience
Center, 6001 Executive Blvd., Suite 3208,
MSC 9529, Bethesda, MD 20892–9529, 301–
496–4056.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.853, Clinical Research
Related to Neurological Disorders; 93.854,
Biological Basis Research in the
Neurosciences, National Institutes of Health,
HHS)
Dated: May 12, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E9–11583 Filed 5–15–09; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Dental &
Craniofacial Research; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
PO 00000
Frm 00026
Fmt 4703
Sfmt 4703
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Dental and Craniofacial Research Special
Emphasis Panel; Review R13.
Date: June 17, 2009.
Time: 1 p.m. to 2 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call)
Contact Person: Mary Kelly, Scientific
Review Officer, Scientific Review Branch,
National Inst. of Dental & Craniofacial
Research, NIH 6701 Democracy Blvd., room
672, MSC 4878, Bethesda, MD 20892–4878,
301–594–4809, mary_kelly@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.121, Oral Diseases and
Disorders Research, National Institutes of
Health, HHS)
Dated: May 11, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E9–11486 Filed 5–15–09; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Biomedical
Imaging and Bioengineering; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Biomedical Imaging and Bioengineering
Special Emphasis Panel—NIBIB Training
2009/10.
Date: June 26, 2009.
Time: 11 a.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy Blvd.,
242, Bethesda, MD 20892. (Virtual Meeting)
Contact Person: Ruixia Zhou, Ph.D.,
Scientific Review Officer, 6707 Democracy
Boulevard, Suite 957, Bethesda, MD 20892.
301–496–4773. zhour@mail.nih.gov.
E:\FR\FM\18MYN1.SGM
18MYN1
Federal Register / Vol. 74, No. 94 / Monday, May 18, 2009 / Notices
Dated: May 11, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E9–11487 Filed 5–15–09; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Notice Correction
The notice published in the May 8,
2009, Federal Register (74 FR 21698)
announcing the opportunity to register
to attend the July 28–29, 2009, NIHsponsored workshop entitled ‘‘Soy
Protein and Isoflavones Research:
Challenges in Designing and Evaluating
Intervention Studies’’ contains an errant
e-mail address for registration purposes.
More specifically, the e-mail address
provided in line 8 of the Registration
section of the notice should read:
twallich@csionweb.com. If you do not
have access to e-mail, please call Ms.
Wallich at 301–670–0270 (not a toll-free
number).
Dated: May 11, 2009.
Paul M. Coates,
Director, Office of Dietary Supplements,
National Institutes of Health.
[FR Doc. E9–11488 Filed 5–15–09; 8:45 am]
Time: 1:30 p.m. to 4:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, DEA/
SRB, Bethesda, MD 20892. (Telephone
Conference Call)
Contact Person: Marilyn Moore-Hoon,
Ph.D., Scientific Review Officer, Scientific
Review Branch, National Institute of Dental
and Craniofacial Research, 6701 Democracy
Blvd., Rm. 676, Bethesda, MD 20892–4878.
301–594–4861. mooremar@nidcr.nih.gov.
Name of Committee: National Institute of
Dental and Craniofacial Research Special
Emphasis Panel, Review F31s, F32s, K08.
Date: June 23, 2009.
Time: 11:30 a.m. to 1 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892.
(Telephone Conference Call)
Contact Person: Raj K. Krishnaraju, Ph.D.,
MS, Scientific Review Officer, Scientific
Review Branch, National Inst of Dental &
Craniofacial Research, National Institutes of
Health, 45 Center Dr. Rm. 4AN 32J, Bethesda,
MD 20892. 301–594–4864.
kkrishna@nidcr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.121, Oral Diseases and
Disorders Research, National Institutes of
Health, HHS)
Place: Hilton Alexandria Old Town, 1767
King Street, Alexandria, VA 22314.
Contact Person: Ilda M. Mckenna, PhD,
Scientific Review Officer, Research Training
Review Branch, Division of Extramural
Activities, National Cancer Institute, 6116
Executive Boulevard, Room 8111, Bethesda,
MD 20892. 301–496–7481.
mckennai@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
Dated: May 11, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E9–11489 Filed 5–15–09; 8:45 am]
National Cancer Institute; Notice of
Closed Meetings
BILLING CODE 4140–01–P
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institutes of Health
National Cancer Institute; Notice of
Closed Meeting
cprice-sewell on PRODPC61 with NOTICES
National Institute of Dental &
Craniofacial Research; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Dental and Craniofacial Research Special
Emphasis Panel, Review of R21, R03 and R34
applications.
Date: June 15, 2009.
VerDate Nov<24>2008
14:36 May 15, 2009
Jkt 217001
23193
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Cancer
Institute Initial Review Group, Subcommittee
J—Population and Patient-Oriented Training.
Date: June 17, 2009.
Time: 7:45 a.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
PO 00000
Frm 00027
Fmt 4703
Sfmt 4703
Dated: May 11, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E9–11483 Filed 5–15–09; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications
and/or contract proposals and the
discussions could disclose confidential
trade secrets or commercial property
such as patentable material, and
personal information concerning
individuals associated with the grant
applications and/or contract proposals,
the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Cancer
Institute Special Emphasis Panel; SBIR Phase
II Bridge Awards to Accelerate the
Development of New Cancer Therapies and
Cancer Imaging Technologies Toward
Commercialization.
Date: June 10–11, 2009.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Gaithersburg Hilton, 620 Perry
Parkway, Gaithersburg, MD 20877.
Contact Person: Lalita D. Palekar, PhD,
Scientific Review Officer, Special Review
and Logistics Branch, Division of Extramural
Activities, National Cancer Institute, 6116
Executive Boulevard, Room 7141, Bethesda,
MD 20892, 301–496–7575,
palekarl@mail.nih.gov.
E:\FR\FM\18MYN1.SGM
18MYN1
Agencies
[Federal Register Volume 74, Number 94 (Monday, May 18, 2009)]
[Notices]
[Pages 23192-23193]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-11487]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Biomedical Imaging and Bioengineering;
Notice of Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Biomedical Imaging and
Bioengineering Special Emphasis Panel--NIBIB Training 2009/10.
Date: June 26, 2009.
Time: 11 a.m. to 4 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Two Democracy Plaza, 6707
Democracy Blvd., 242, Bethesda, MD 20892. (Virtual Meeting)
Contact Person: Ruixia Zhou, Ph.D., Scientific Review Officer,
6707 Democracy Boulevard, Suite 957, Bethesda, MD 20892. 301-496-
4773. zhour@mail.nih.gov.
[[Page 23193]]
Dated: May 11, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. E9-11487 Filed 5-15-09; 8:45 am]
BILLING CODE 4140-01-P